{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:31:02Z","timestamp":1793694662340,"version":"4.5.1"},"reference-count":314,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460893"],"award-info":[{"award-number":["82460893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108437","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:27:58Z","timestamp":1788823678000},"page":"108437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reconfiguring the macrophage-centric intercellular network in pulmonary fibrosis: Emerging perspectives and therapeutic opportunities"],"prefix":"10.1016","volume":"233","author":[{"given":"Yujie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6434-9314","authenticated-orcid":false,"given":"Senyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108437_bib1","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI60323","article-title":"Pulmonary fibrosis: patterns and perpetrators","volume":"122","author":"Noble","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108437_bib2","doi-asserted-by":"crossref","first-page":"334S","DOI":"10.1378\/chest.122.6_suppl.334S","article-title":"Overview of pulmonary fibrosis","volume":"122","author":"Green","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2026.108437_bib3","article-title":"Differences in disease characteristics and outcomes as determined by biological sex in a large UK idiopathic pulmonary fibrosis population: analysis from the british thoracic society, interstitial lung disease registry data","volume":"12","author":"Mulholland","year":"2025","journal-title":"BMJ Open. Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib4","doi-asserted-by":"crossref","unstructured":"ell, T.J. Corte, V. Cottin, A.R. Glanville, M.K. Glassberg, M. Griese, G.M. Hunninghake, K.A. Johannson, M.P. Keane, J.S. Kim, M. Kolb, T.M. Maher, J.M. Oldham, A.J. Podolanczuk, I.O. Rosas, F.J. Martinez, I. Noth, D.A. Schwartz, Genetics and genomics of pulmonary fibrosis: Charting the molecular landscape and shaping precision medicine, Am. J. Respir. Crit. Care Med. 210 (2024) 401\u2013423.","DOI":"10.1164\/rccm.202401-0238SO"},{"key":"10.1016\/j.phrs.2026.108437_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12890-025-03836-1","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis","volume":"25","author":"Golchin","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib6","first-page":"343","article-title":"Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis","volume":"11","author":"Meyer","year":"2017","journal-title":"Expert. Rev. Respir. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12890-021-01783-1","article-title":"Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis","volume":"21","author":"Finnerty","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib8","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"FIBRONEER-IPF trial investigators, nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib9","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1205948","article-title":"Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib11","doi-asserted-by":"crossref","DOI":"10.5500\/wjt.v15.i3.101866","article-title":"Optimizing patient outcomes in interstitial lung disease through pre- and post-transplant management strategies","volume":"15","author":"Georgakopoulou","year":"2025","journal-title":"World J. Transplant."},{"key":"10.1016\/j.phrs.2026.108437_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/thorax-2024-222060","article-title":"Epithelial damage and ageing: the perfect storm","volume":"80","author":"Hewitt","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2026.108437_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2026.108437_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108437_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.201609","article-title":"Bispecific targeting of CHI3L1 and PD-1 as a therapeutic strategy for pulmonary fibrosis","volume":"11","author":"Jeong","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.108437_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2024.10.002","article-title":"Blockade of TREM2 ameliorates pulmonary inflammation and fibrosis by modulating sphingolipid metabolism","volume":"275","author":"Gu","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib18","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20251114","article-title":"Tet2 deficiency-induced expansion of monocyte-derived macrophages promotes liver fibrosis","volume":"223","author":"Feng","year":"2026","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib19","first-page":"23","article-title":"Protective role of natural products in pulmonary fibrosis through immuneregulation","volume":"24","author":"Su","year":"2026","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10735-025-10646-6","article-title":"EChinacoside ameliorates bleomycin-induced idiopathic pulmonary fibrosis by regulating macrophage polarization","volume":"57","author":"Zhang","year":"2025","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.phrs.2026.108437_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41421-025-00859-0","article-title":"Lineage tracing reveals the origins and dynamics of macrophages in lung injury and repair","volume":"12","author":"Jin","year":"2026","journal-title":"Cell. Discov."},{"key":"10.1016\/j.phrs.2026.108437_bib22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","article-title":"Biology of lung macrophages in health and disease","volume":"55","author":"Aegerter","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108437_bib23","first-page":"650","article-title":"advances on physiology and pathology of subpopulations of macrophages in the lung tissue","volume":"53","author":"Zhong","year":"2024","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.phrs.2026.108437_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-022-05660-7","article-title":"Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE","volume":"614","author":"Pernet","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108437_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114569","article-title":"IL-4-induced SOX9 confers lineage plasticity to aged adult lung stem cells","volume":"43","author":"Cai","year":"2024","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444964","article-title":"Macrophage polarization and its impact on idiopathic pulmonary fibrosis","volume":"15","author":"Ge","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1638345","article-title":"Macrophage subtypes and pathways in autoimmune interstitial lung diseases: Potential therapeutic targets","volume":"16","author":"Tyagi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOL.0000000000000987","article-title":"Alveolar macrophages: Guardians of the alveolar lipid galaxy","volume":"36","author":"Little","year":"2025","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2026.108437_bib29","unstructured":"TREM2 insufficiency protects against pulmonary fibrosis by inhibiting M2 macrophage polarization - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/37003186\/ (accessed July 16, 2026)."},{"key":"10.1016\/j.phrs.2026.108437_bib30","article-title":"Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics","volume":"6","author":"Peng","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.phrs.2026.108437_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00476-23","article-title":"Macrophage fate: to kill or not to kill?","volume":"92","author":"Marrufo","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2026.108437_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: friend or foe in idiopathic pulmonary fibrosis","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib33","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.7150\/ijbs.123492","article-title":"Macrophage immunometabolism in pulmonary homeostasis and chronic lung diseases","volume":"21","author":"Xie","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12964-024-01557-2","article-title":"The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: A review","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phrs.2026.108437_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12964-024-01557-2","article-title":"The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review","volume":"22","author":"Zhou","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phrs.2026.108437_bib36","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.3390\/ijms252111669","article-title":"Single-cell RNA sequencing reveals monocyte-derived interstitial macrophages with a pro-fibrotic phenotype in bleomycin-induced pulmonary fibrosis","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.phrs.2026.108437_bib37","first-page":"00003","article-title":"Integrated human and mouse single-cell profiling reveals immune-stromal niche driving silicosis","volume":"S1933-0219","author":"Begka","year":"2026","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/cells12030402","article-title":"Interstitial macrophages lead early stages of bleomycin-induced lung fibrosis and induce fibroblasts activation","volume":"12","author":"Lib\u00f3rio-Ramos","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108437_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41421-025-00859-0","article-title":"Lineage tracing reveals the origins and dynamics of macrophages in lung injury and repair","volume":"12","author":"Jin","year":"2026","journal-title":"Cell. Discov."},{"key":"10.1016\/j.phrs.2026.108437_bib41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s12276-025-01426-z","article-title":"PGC-1\u03b1 mediates migrasome secretion accelerating macrophage-myofibroblast transition and contributing to sepsis-associated pulmonary fibrosis","volume":"57","author":"Peng","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178159","article-title":"Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: A recent update","volume":"1006","author":"Sharma","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108820","article-title":"The role of macrophages in asthma-related fibrosis and remodelling","volume":"269","author":"Yang","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib44","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41590-024-01975-x","article-title":"Profibrotic monocyte-derived alveolar macrophages are expanded in patients with persistent respiratory symptoms and radiographic abnormalities after COVID-19","volume":"25","author":"Bailey","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib45","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.3390\/ijms231911443","article-title":"Plasticity towards rigidity: A macrophage conundrum in pulmonary fibrosis","volume":"23","author":"Sari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1165\/rcmb.2015-0020TR","article-title":"Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis","volume":"53","author":"Craig","year":"2015","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115727","article-title":"JTE-013 reduces inflammation and improves pulmonary fibrosis by regulating the TRAF2\/NF - \u03baB\/IGF-1 signaling pathway and macrophage polarization","volume":"167","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/cells10020436","article-title":"Macrophages in Lung Injury, Repair, and Fibrosis","volume":"10","author":"Cheng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108437_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155903","article-title":"Pathological interplay of NF-\u03baB and M1 macrophages in chronic inflammatory lung diseases","volume":"269","author":"Alanazi","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.phrs.2026.108437_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.matbio.2018.08.002","article-title":"The receptor for hyaluronan-mediated motility (CD168) promotes inflammation and fibrosis after acute lung injury","author":"Cui","year":"2019","journal-title":"Matrix Biol. 7879"},{"key":"10.1016\/j.phrs.2026.108437_bib51","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/jcp.26112","article-title":"TNF-\u03b1-induced NF-\u03baB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis","volume":"233","author":"Hou","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2019.03.061","article-title":"Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib","volume":"72","author":"Bellamri","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1165\/rcmb.2022-0021OC","article-title":"Antifibrotic drug nintedanib inhibits CSF1R to promote IL-4-associated tissue repair macrophages","volume":"68","author":"Watson","year":"2023","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/cbin.10788","article-title":"M2 macrophages induce EMT through the TGF-\u03b2\/Smad2 signaling pathway","volume":"41","author":"Zhu","year":"2017","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.phrs.2026.108437_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105795","article-title":"Potential role of M2 macrophage polarization in ventilator-induced lung fibrosis","volume":"75","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188734","article-title":"Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis","volume":"135","author":"Yadav","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108437_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00615-2024","article-title":"Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation","volume":"65","author":"Kim","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-025-02566-5","article-title":"The interplay between M2-like macrophages and Th17.1 cells promotes the progression of early-stage sarcoidosis","volume":"24","author":"Zhao","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phrs.2026.108437_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphys.2017.00159","article-title":"Bosutinib therapy ameliorates lung inflammation and fibrosis in experimental silicosis","volume":"8","author":"Carneiro","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41590-025-02217-4","article-title":"Genetic variation in the activity of a TREM2-p53 signaling axis determines oxygen-induced lung injury","volume":"26","author":"Abe","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2025.180609","article-title":"Particulate matter 2.5 promotes pulmonary fibrosis in allergic asthma through macrophage reprogramming toward the M2 phenotype","volume":"1002","author":"Kim","year":"2025","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.phrs.2026.108437_bib62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/toxsci\/kfy039","article-title":"Cypermethrin promotes lung cancer metastasis via modulation of macrophage polarization by targeting MicroRNA-155\/Bcl6","volume":"163","author":"Huang","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib63","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41467-025-57024-0","article-title":"TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity","volume":"16","author":"Cui","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41423-025-01288-5","article-title":"Targeting lp-PLA2 inhibits profibrotic monocyte-derived macrophages in silicosis through restoring cardiolipin-mediated mitophagy","volume":"22","author":"Li","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib65","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41467-025-59641-1","article-title":"Let-7 restrains an epigenetic circuit in AT2 cells to prevent fibrogenic intermediates in pulmonary fibrosis","volume":"16","author":"Seasock","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101100118","article-title":"Resetting proteostasis with ISRIB promotes epithelial differentiation to attenuate pulmonary fibrosis","volume":"118","author":"Watanabe","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2026.108437_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112131","article-title":"Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner","volume":"42","author":"Hoeft","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85530","article-title":"Systems level identification of a matrisome-associated macrophage polarisation state in multi-organ fibrosis","volume":"12","author":"Ouyang","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2026.108437_bib71","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bbapap.2012.10.015","article-title":"Platelet-derived growth factors and their receptors: structural and functional perspectives","volume":"1834","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2026.108437_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01544-2023","article-title":"YAP\/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury","volume":"65","author":"Mia","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113931","article-title":"Inhibition of HIF-1\u03b1 ameliorates pulmonary fibrosis by suppressing M2 macrophage polarization through PRMT1\/STAT6 signals","volume":"146","author":"Liang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib74","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.3390\/ijms25137490","article-title":"Unveiling the cutting-edge impact of polarized macrophage-derived extracellular vesicles and MiRNA signatures on TGF-\u03b2 regulation within lung fibroblasts","volume":"25","author":"Casara","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1261483","article-title":"Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death","volume":"14","author":"Carignon","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib76","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-026-11086-9","article-title":"Unlocking alveolar regeneration: AT2 stem cells, signaling networks, and therapeutic frontiers","author":"Zhang","year":"2026","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.999600","article-title":"Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib78","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1038\/s41467-023-40617-y","article-title":"Autocrine TGF-\u03b2-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis","volume":"14","author":"Enomoto","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib79","first-page":"812","article-title":"Epithelial cell dysfunction in pulmonary fibrosis: mechanisms, interactions, and emerging therapeutic targets","volume":"18","author":"Wang","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.phrs.2026.108437_bib80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 regulation of TGF-\u03b21-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado1227","article-title":"Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury","volume":"9","author":"Ruscitti","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib82","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.immuni.2021.04.001","article-title":"Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection","volume":"54","author":"Zhu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108437_bib83","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12931-025-03359-7","article-title":"Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase","volume":"26","author":"Shang","year":"2025","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr2277","article-title":"Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling","volume":"17","author":"Kim","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib85","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/cells10020436","article-title":"Macrophages in lung injury, repair, and fibrosis","volume":"10","author":"Cheng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108437_bib86","doi-asserted-by":"crossref","first-page":"C1046","DOI":"10.1152\/ajpcell.00302.2023","article-title":"Monocytes and macrophages: Emerging mechanisms and novel therapeutic targets in pulmonary fibrosis","volume":"325","author":"Perrot","year":"2023","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib87","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.18632\/aging.204309","article-title":"Natural variation in macrophage polarization and function impact pneumocyte senescence and susceptibility to fibrosis","volume":"14","author":"Chung","year":"2022","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.phrs.2026.108437_bib88","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.stem.2020.06.020","article-title":"Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration","volume":"27","author":"Choi","year":"2020","journal-title":"Cell. Stem Cell."},{"issue":"8","key":"10.1016\/j.phrs.2026.108437_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123637","article-title":"Single cell RNA sequencing identifies TGF\u03b2 as a key regenerative cue following LPS-induced lung injury","volume":"5","author":"Riemondy","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.phrs.2026.108437_bib90","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/tox.23641","article-title":"Molybdenum and cadmium co-exposure promotes M1 macrophage polarization through oxidative stress-mediated inflammatory response and induces pulmonary fibrosis in shaoxing ducks (anas platyrhyncha)","volume":"37","author":"Huang","year":"2022","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.phrs.2026.108437_bib91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41419-020-2329-z","article-title":"Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization","volume":"11","author":"Wang","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.phrs.2026.108437_bib92","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3390\/biomedicines12071586","article-title":"The role of fibroblasts in skin homeostasis and repair","volume":"12","author":"Boraldi","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108437_bib93","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: Origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108437_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112184","article-title":"Abnormal matrix viscosity promotes the progression of radiation-induced pulmonary fibrosis through integrin-\u03b21\/vinculin\/FAK pathway in the presclerotic stage","volume":"137","author":"Chen","year":"2026","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108437_bib95","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/polym17060822","article-title":"Extracellular matrix stiffness: Mechanotransduction and mechanobiological response-driven strategies for biomedical applications targeting fibroblast inflammation","volume":"17","author":"Tiskratok","year":"2025","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.phrs.2026.108437_bib96","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00482-2023","article-title":"Evidence for a lipofibroblast-to-Cthrc1 + myofibroblast reversible switch during the development and resolution of lung fibrosis in young mice","volume":"65","author":"Lingampally","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib97","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.227900","article-title":"The myofibroblast at a glance","volume":"133","author":"Pakshir","year":"2020","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib98","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s12276-022-00901-1","article-title":"ASK1-ER stress pathway-mediated fibrotic-EV release contributes to the interaction of alveolar epithelial cells and lung fibroblasts to promote mechanical ventilation-induced pulmonary fibrosis","volume":"54","author":"Tang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib99","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2024.06.001","article-title":"Metabolism and bioenergetics in the pathophysiology of organ fibrosis","volume":"222","author":"Miguel","year":"2024","journal-title":"Free. Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117661","article-title":"miR-207 mitigates silica-induced pulmonary fibrosis by suppressing fibroblast-to-myofibroblast transition via multi-target modulation of the TGF-\u03b21\/SMADs signaling pathways in mice","volume":"507","author":"Du","year":"2026","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib101","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1165\/rcmb.2020-0516OC","article-title":"Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung-Function Decline","volume":"64","author":"Vera","year":"2021","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/FJC.0000000000001735","article-title":"Fibroblast activation protein promotes pulmonary artery hypertension via activation of the PTEN\/PI3K\/akt pathway","volume":"86","author":"Zhu","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.136629","article-title":"Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis","volume":"483","author":"Zhang","year":"2025","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.phrs.2026.108437_bib104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: Molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib105","doi-asserted-by":"crossref","first-page":"L495","DOI":"10.1152\/ajplung.00458.2021","article-title":"IL10 trains macrophage profibrotic function after lung injury","volume":"322","author":"Bhattacharyya","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150836","article-title":"TLR2-EGR1 signaling axis modulates TGF\u03b21-induced differentiation of fibroblasts into myofibroblasts in pulmonary fibrosis","volume":"736","author":"Jung","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib107","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1165\/rcmb.2024-0527OC","article-title":"von willebrand factor deficiency inhibits endothelial-to-mesenchymal transition to attenuate pulmonary fibrosis","volume":"73","author":"Wang","year":"2025","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib108","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.3390\/ijms26146945","article-title":"Amphiregulin in fibrotic diseases and cancer","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib109","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.immuni.2019.01.008","article-title":"A macrophage-pericyte axis directs tissue restoration via amphiregulin-induced transforming growth factor beta activation","volume":"50","author":"Minutti","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108437_bib110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","article-title":"Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship","volume":"87","author":"Wipff","year":"2008","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2019.01.011","article-title":"Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis","volume":"366","author":"Li","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib112","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3389\/fimmu.2018.01776","article-title":"S100A4+ Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.200609-1279OC","article-title":"Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis","volume":"176","author":"Baran","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2026.108437_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200729","article-title":"Alveolar macrophage-fibroblast crosstalk includes a feedforward arginase 1\/IL-6 circuit implicated in pulmonary fibrosis","volume":"135","author":"Budinger","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108437_bib115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","article-title":"Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: Insights from the faSScinate clinical trial in systemic sclerosis","volume":"77","author":"Denton","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2026.108437_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177472","article-title":"Targeting endothelial cells: A novel strategy for pulmonary fibrosis treatment","volume":"997","author":"Zhang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib117","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/biomedicines12030632","article-title":"Roles of macrophages and endothelial cells and their crosstalk in acute lung injury","volume":"12","author":"Osorio-Valencia","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108437_bib118","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1165\/rcmb.2024-0046OC","article-title":"Lung fibrosis is linked to increased endothelial cell activation and dysfunctional vascular barrier integrity","volume":"71","author":"Flie\u00dfer","year":"2024","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib119","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4196\/kjpp.25.236","article-title":"Endothelial to mesenchymal transition: a central mechanism in diabetes-induced vascular pathology","volume":"29","author":"Vu","year":"2025","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib121","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.70032","article-title":"TRIM34-mediated ubiquitination and degradation of HIF-1A regulates glycolysis in endothelial cells, inhibits angiogenesis, and relieves the progression of lung fibrosis","volume":"27","author":"Yang","year":"2025","journal-title":"J. Gene Med."},{"key":"10.1016\/j.phrs.2026.108437_bib123","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/biom15101452","article-title":"Inflammaging and senescence-driven extracellular matrix remodeling in age-associated cardiovascular disease","volume":"15","author":"M\u0142ynarska","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.108437_bib124","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1038\/s41467-024-49545-x","article-title":"Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis","volume":"15","author":"Raslan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib125","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1038\/s41467-022-31890-4","article-title":"Dysfunctional ERG signaling drives pulmonary vascular aging and persistent fibrosis","volume":"13","author":"Caporarello","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm.4035","article-title":"Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis","volume":"22","author":"Cao","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108437_bib127","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108437_bib128","first-page":"3","article-title":"STAT1 activation and STAT1-dependent immune-response gene ICAM-1 expression in alveolar macrophages of rats suffered from interstitial pulmonary fibrosis, Xi Bao Yu Fen Zi Mian Yi","volume":"19","author":"Fan","year":"2003","journal-title":"Xue Za Zhi"},{"key":"10.1016\/j.phrs.2026.108437_bib129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41419-020-2329-z","article-title":"Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization","volume":"11","author":"Wang","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.phrs.2026.108437_bib130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/cells11060986","article-title":"EGFR signaling in lung fibrosis","volume":"11","author":"Schramm","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108437_bib131","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.1038\/s41598-017-17007-8","article-title":"Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration","volume":"7","author":"Ishida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib132","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00460-2019","article-title":"CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases","volume":"55","author":"Greiffo","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib133","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108437_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248889","article-title":"Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms","volume":"16","author":"Karman","year":"2021","journal-title":"PLoS. One"},{"key":"10.1016\/j.phrs.2026.108437_bib135","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.phrs.2026.108437_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1718092","article-title":"Neutrophils as key drivers of pulmonary fibrosis: Unveiling mechanisms and therapeutic implications","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib137","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-020-08779-5","article-title":"The Role of Mast Cells in IgE-Independent Lung Diseases","volume":"58","author":"Komi","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114584","article-title":"Antifibrotic effects of IL-12-treated natural killer cells on collagen type I regulation in lung fibroblasts","volume":"449","author":"Okuno","year":"2025","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib139","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jmii.2025.08.004","article-title":"NADPH oxidase 4 deficiency enhances dendritic cell-mediated IL-12 production and Th1 responses in mycobacterium tuberculosis infection","volume":"59","author":"Lee","year":"2026","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.phrs.2026.108437_bib140","article-title":"CD4+T and CD8+T cells profile in lung inflammation and fibrosis: Targets and potential therapeutic drugs","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib141","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12016-025-09045-2","article-title":"Targeting IL-13 and IL-4 in asthma: Therapeutic implications on airway remodeling in severe asthma","volume":"68","author":"Sahnoon","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1609509","article-title":"Revisiting pulmonary fibrosis: Inflammatory dynamics of the lipofibroblast-to-inflammatory lipofibroblast-to-activated myofibroblast reversible switch","volume":"16","author":"Panagiotidis","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib143","article-title":"The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib144","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181775","article-title":"Reactivation of CTLA4-expressing T cells accelerates resolution of lung fibrosis in a humanized mouse model","volume":"135","author":"Yadav","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2026.108437_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1437767","article-title":"Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences","volume":"15","author":"Cocconcelli","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adt8858","article-title":"Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia","volume":"11","author":"Ngo","year":"2026","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1682649","article-title":"Role of toll-like receptors in pulmonary immunity: Mechanisms and therapeutic implications","volume":"16","author":"Qu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib148","first-page":"158","article-title":"Bcl-xL targeting eliminates ageing tumor-promoting neutrophils and inhibits lung tumor growth","volume":"16","author":"Bodac","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib149","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1589923","article-title":"Specialized pro-resolving mediators in neutrophil apoptosis regulation: Unlocking novel therapeutic potential in kidney diseases","volume":"16","author":"Kang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1638345","article-title":"Macrophage subtypes and pathways in autoimmune interstitial lung diseases: potential therapeutic targets","volume":"16","author":"Tyagi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib152","article-title":"Granulocyte macrophage-colony stimulating factor produces a splenic subset of monocyte-derived dendritic cells that efficiently polarize T helper type 2 cells in response to blood-borne antigen","volume":"12","author":"Ryu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib153","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40348-016-0055-5","article-title":"Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy","volume":"3","author":"R\u00f6sler","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.phrs.2026.108437_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1440918","article-title":"Tff1-expressing tregs in lung prevent exacerbation of bleomycin-induced pulmonary fibrosis","volume":"15","author":"Okamoto","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111774","article-title":"Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1\/M2 macrophage polarization","volume":"131","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib156","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1165\/rcmb.2002-0009OC","article-title":"Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis","volume":"27","author":"Belperio","year":"2002","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib157","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12931-018-0783-2","article-title":"Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation","volume":"19","author":"Kamio","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib159","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1096\/fj.201700289R","article-title":"IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis","volume":"31","author":"Cipolla","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.108437_bib160","article-title":"CD4+T and CD8+T cells profile in lung inflammation and fibrosis: Targets and potential therapeutic drugs","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib161","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41467-023-37873-3","article-title":"Lung-specific MCEMP1 functions as an adaptor for KIT to promote SCF-mediated mast cell proliferation","volume":"14","author":"Choi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib162","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae021","article-title":"CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1\u03b1-mediated lactate production","volume":"16","author":"Yan","year":"2024","journal-title":"J. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.136629","article-title":"Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis","volume":"483","author":"Zhang","year":"2025","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.phrs.2026.108437_bib164","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/biom14020146","article-title":"lncRNA profiling of exosomes and its communication role in regulating silica-stimulated macrophage apoptosis and fibroblast activation","volume":"14","author":"Ban","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.108437_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1708716","article-title":"Immunobiology of pulmonary fibrosis","volume":"16","author":"Bindu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib166","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cytogfr.2025.08.003","article-title":"From senescence to scarring: Exploring TGF-\u03b2 signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis","volume":"86","author":"Bhardwaj","year":"2025","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.phrs.2026.108437_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118267","article-title":"Ugonin L ameliorates pulmonary fibrosis as a novel T\u03b2Rs inhibitor by regulating the TGF-\u03b2\/T\u03b2Rs signaling and autophagy","volume":"189","author":"Hsia","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108437_bib168","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","article-title":"Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis","volume":"631","author":"Tsukui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108437_bib169","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41420-023-01310-7","article-title":"Regulatory T cell and macrophage crosstalk in acute lung injury: Future perspectives","volume":"9","author":"Guan","year":"2023","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.phrs.2026.108437_bib170","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108437_bib171","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1038\/s41598-025-89874-5","article-title":"OM85 ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting notch expression and modulating the IFN-\u03b3\/IL-4 ratio","volume":"15","author":"Yu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1630990","article-title":"Advances in interleukin-10-based therapies for pulmonary diseases: Focus on targeted lung delivery systems","volume":"16","author":"Tian","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib173","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12890-024-03260-x","article-title":"IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN\/AKT\/ERK pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib174","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1164\/ajrccm.162.6.9908097","article-title":"Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis","volume":"162","author":"Dohi","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2026.108437_bib175","article-title":"Current understanding of pulmonary fibrosis: pathogenesis, diagnosis, and therapeutic approaches","volume":"2025","author":"Cui","year":"2025","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib176","article-title":"The role and therapeutic targeting of the CCL2\/CCR2 signaling axis in inflammatory and fibrotic diseases","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib177","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1165\/rcmb.2025-0010OC","article-title":"Sequential roles of VLA-4\/VCAM-1 interactions and CXCR4\/CXCL12 cues in the early phases of injured lung regeneration by lung cell transplantation","volume":"74","author":"Su","year":"2026","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib178","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/cmi.2017.118","article-title":"Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases","volume":"15","author":"Cockx","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib179","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41392-025-02532-0","article-title":"Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies","volume":"11","author":"Chen","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib180","first-page":"3160s","article-title":"Radioimmunotherapy using vascular targeted 213Bi: The role of tumor necrosis factor alpha in the development of pulmonary fibrosis","volume":"5","author":"Davis","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108437_bib181","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","article-title":"The ins-and-outs of exosome biogenesis, secretion, and internalization","volume":"34","author":"Arya","year":"2024","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib182","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43556-025-00280-9","article-title":"Exosomes in inflammation and cancer: From bench to bedside applications","volume":"6","author":"Huang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.phrs.2026.108437_bib183","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s11658-022-00384-y","article-title":"The role of macrophage subtypes and exosomes in immunomodulation","volume":"27","author":"Gharavi","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.phrs.2026.108437_bib184","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s41418-021-00750-x","article-title":"Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response","volume":"28","author":"Feng","year":"2021","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.phrs.2026.108437_bib185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: A randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2026.108437_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0255-x","article-title":"microRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model","volume":"51","author":"Yao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153310","article-title":"Macrophage derived miR-7219-3p-containing exosomes mediate fibroblast trans-differentiation by targeting SPRY1 in silicosis","volume":"479","author":"Niu","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2026.108437_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.110253","article-title":"Exosomal miR-125a-5p derived from silica-exposed macrophages induces fibroblast transdifferentiation","volume":"192","author":"Wang","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.phrs.2026.108437_bib189","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1465-9921-14-9","article-title":"Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms","volume":"14","author":"Akram","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib190","article-title":"Functions and mechanisms of UC-MSC-derived exosomal miR-486-5p in pulmonary fibrosis","volume":"15","author":"Shi","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2026.108437_bib191","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1111\/jcmm.15989","article-title":"Low let-7d exosomes from pulmonary vascular endothelial cells drive lung pericyte fibrosis through the TGF\u03b2RI\/FoxM1\/smad\/\u03b2-catenin pathway","volume":"24","author":"Xie","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib192","doi-asserted-by":"crossref","first-page":"H520","DOI":"10.1152\/ajpheart.00373.2020","article-title":"Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1\u03b1\/Notch1\/PDGFR\u03b2\/YAP1\/Twist1 axis in vitro","volume":"320","author":"Wang","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib193","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/thoraxjnl-2019-214077","article-title":"Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p","volume":"75","author":"Guiot","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2026.108437_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108075","article-title":"Exosomes derived from induced pluripotent stem cells suppresses M2-type macrophages during pulmonary fibrosis via miR-302a-3p\/TET1 axis","volume":"99","author":"Zhou","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib195","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3389\/fimmu.2018.01486","article-title":"Apoptotic cell-derived extracellular vesicles: More than just debris","volume":"9","author":"Caruso","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib196","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20101157","article-title":"Find-me and eat-me signals in apoptotic cell clearance: Progress and conundrums","volume":"207","author":"Ravichandran","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib197","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib198","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2020.00219","article-title":"Crystalline silica impairs efferocytosis abilities of human and mouse macrophages: Implication for silica-associated systemic sclerosis","volume":"11","author":"Lescoat","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib199","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12931-023-02424-3","article-title":"Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis","volume":"24","author":"She","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2010.46","article-title":"The role of defective clearance of apoptotic cells in systemic autoimmunity","volume":"6","author":"Mu\u00f1oz","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2026.108437_bib201","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1189\/jlb.3A1116-483R","article-title":"Macrophage-derived apoptotic bodies promote the proliferation of the recipient cells via shuttling microRNA-221\/222","volume":"101","author":"Zhu","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2026.108437_bib203","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.3390\/ijms24065346","article-title":"Hepatocyte-specific triggering of hepatic stellate cell profibrotic activation by apoptotic bodies: The role of hepatoma-derived growth factor, HIV, and ethanol","volume":"24","author":"New-Aaron","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib204","first-page":"146","article-title":"Current research and development of anti-pulmonary fibrosis drugs","volume":"39","author":"Yuanyi","year":"2025","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2026.108437_bib205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-022-02047-0","article-title":"Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): An open-label extension study","volume":"23","author":"Raghu","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib206","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/jama.2023.5355","article-title":"ISABELA 1 and 2 Investigators, Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: The ISABELA 1 and 2 randomized clinical trials","volume":"329","author":"Maher","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2026.108437_bib207","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ Open. Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib208","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/13543784.2020.1773790","article-title":"Pamrevlumab for the treatment of idiopathic pulmonary fibrosis","volume":"29","author":"Sgalla","year":"2020","journal-title":"Expert. Opin. Invest. Drugs"},{"key":"10.1016\/j.phrs.2026.108437_bib209","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): A phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib210","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","article-title":"FG-3019 anti-connective tissue growth factor monoclonal antibody: Results of an open-label clinical trial in idiopathic pulmonary fibrosis","volume":"47","author":"Raghu","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: A randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib212","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2026.108437_bib213","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01130-2018","article-title":"SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)","volume":"52","author":"Raghu","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib214","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02442-2019","article-title":"Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Maher","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis","volume":"197","author":"Parker","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2026.108437_bib216","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00663-2018","article-title":"Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis","volume":"53","author":"Khalil","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib217","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1183\/13993003.01558-2014","article-title":"CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib218","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2022","article-title":"GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial","volume":"61","author":"Strambu","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib219","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02559-2020","article-title":"Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Hirani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2026.108437_bib220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acsmedchemlett.0c00679","article-title":"Discovery of selective transforming growth factor \u03b2 type II receptor inhibitors as antifibrosis agents","volume":"12","author":"Miwa","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108437_bib221","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1358\/dnp.2010.23.5.1444206","article-title":"PRM-151 (recombinant human serum amyloid P\/pentraxin 2) for the treatment of fibrosis","volume":"23","author":"Duffield","year":"2010","journal-title":"Drug. N. Perspect."},{"key":"10.1016\/j.phrs.2026.108437_bib222","doi-asserted-by":"crossref","unstructured":"L. Richeldi, C. Schiffman, J. Behr, Y. Inoue, T.J. Corte, V. Cottin, R.G. Jenkins, S.D. Nathan, G. Raghu, S.L.F. Walsh, P.K. Jayia, N. Kamath, F.J. Martinez, Zinpentraxin alfa for idiopathic pulmonary fibrosis: The randomized phase III STARSCAPE trial, Am. J. Respir. Crit. Care Med. 209 (n.d.) 1132\u20131140.","DOI":"10.1164\/rccm.202401-0116OC"},{"key":"10.1016\/j.phrs.2026.108437_bib223","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1164\/rccm.202405-0977OC","article-title":"Efficacy and safety of admilparant, an LPA1 antagonist, in pulmonary fibrosis: A phase 2 randomized clinical trial","volume":"211","author":"Corte","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2026.108437_bib224","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.chest.2025.04.003","article-title":"Effect of admilparant, a lysophosphatidic acid receptor 1 antagonist, on disease progression in pulmonary fibrosis","volume":"168","author":"Kreuter","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2026.108437_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106566","article-title":"Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases","volume":"187","author":"Xiang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120350","article-title":"Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model","volume":"598","author":"Zhang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2026.108437_bib227","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2026.108437_bib228","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2026.108437_bib229","article-title":"CC-90001, a c-jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial","volume":"9","author":"Popmihajlov","year":"2022","journal-title":"BMJ Open. Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib230","article-title":"Population pharmacokinetic model for oral ORIN1001 in Chinese patients with advanced solid tumors","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib231","doi-asserted-by":"crossref","unstructured":"L. Lancaster, V. Cottin, M. Ramaswamy, W.A. Wuyts, R.G. Jenkins, M.B. Scholand, M. Kreuter, C. Valenzuela, C.J. Ryerson, J. Goldin, G.H.J. Kim, M. Jurek, M. Decaris, A. Clark, S. Turner, C.N. Barnes, H.E. Achneck, G.P. Cosgrove, \u00c9.A. Lefebvre, K.R. Flaherty, Bexotegrast in patients with idiopathic pulmonary fibrosis: The INTEGRIS-IPF clinical trial, Am. J. Respir. Crit. Care Med. 210 (n.d.) 424\u2013434.","DOI":"10.1164\/rccm.202403-0636OC"},{"key":"10.1016\/j.phrs.2026.108437_bib232","doi-asserted-by":"crossref","first-page":"L258","DOI":"10.1152\/ajplung.00165.2021","article-title":"Coagulation factor-XII induces interleukin-6 by primary lung fibroblasts: A role in idiopathic pulmonary fibrosis","volume":"322","author":"Jaffar","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib233","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13543784.2025.2510667","article-title":"Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease","volume":"34","author":"Ngo","year":"2025","journal-title":"Expert. Opin. Invest. Drugs"},{"key":"10.1016\/j.phrs.2026.108437_bib234","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S2213-2600(25)00239-5","article-title":"Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial","volume":"13","author":"Maher","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111471","article-title":"Inhibition of NF-\u03baB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis","volume":"138","author":"Jaffar","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108437_bib236","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17512433.2024.2396121","article-title":"Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)","volume":"17","author":"Aribindi","year":"2024","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib237","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/cts.13518","article-title":"Safety, tolerability, pharmacokinetic\/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects","volume":"16","author":"Park","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib238","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/cts.13180","article-title":"A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab","volume":"15","author":"McKenzie","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib239","first-page":"1481","article-title":"The antifibrotic effect and mechanism of a novel tyrosine kinase inhibitor, ZSP1603, in preclinical models of pulmonary fibrosis","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib240","article-title":"Phase 2 study design and analysis approach for BBT-877: An autotaxin inhibitor targeting idiopathic pulmonary fibrosis","volume":"12","author":"Maher","year":"2025","journal-title":"BMJ Open. Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib241","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216940","article-title":"Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1","volume":"15","author":"Yoon","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib242","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/cpdd.1417","article-title":"Pharmacokinetics of fipaxalparant, a small-molecule selective negative allosteric modulator of lysophosphatidic acid receptor 1, and the effect of food in healthy volunteers","volume":"13","author":"Song","year":"2024","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"10.1016\/j.phrs.2026.108437_bib243","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/cts.13654","article-title":"A first-in-human phase I study of SHR-1906, a humanized monoclonal antibody against connective tissue growth factor, in healthy participants","volume":"16","author":"Song","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib244","doi-asserted-by":"crossref","first-page":"15527","DOI":"10.1021\/acs.jmedchem.0c01179","article-title":"Discovery of OATD-01, a first-in-class chitinase inhibitor as potential new therapeutics for idiopathic pulmonary fibrosis","volume":"63","author":"Koralewski","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108437_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106552","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective autotaxin inhibitor, in healthy subjects: a phase I randomized placebo-controlled trial","volume":"189","author":"Yang","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib246","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/jamp.2023.0014","article-title":"A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis","volume":"36","author":"Doi","year":"2023","journal-title":"J. Aerosol Med. Pulm. Drug. Deliv."},{"key":"10.1016\/j.phrs.2026.108437_bib247","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1038\/s41467-025-58568-x","article-title":"Preclinical concept studies showing advantage of an inhaled anti-CTGF\/CCN2 protein for pulmonary fibrosis treatment","volume":"16","author":"Neiens","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib248","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4049\/jimmunol.1502479","article-title":"Bone marrow CD11c+ cell-derived amphiregulin promotes pulmonary fibrosis","volume":"197","author":"Ding","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.108437_bib249","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12931-022-02285-2","article-title":"Amphiregulin induces CCN2 and fibronectin expression by TGF-\u03b2 through EGFR-dependent pathway in lung epithelial cells","volume":"23","author":"Cheng","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib250","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13543776.2021.1867106","article-title":"An updated patent review of autotaxin inhibitors (2017-present)","volume":"31","author":"Tan","year":"2021","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.phrs.2026.108437_bib251","doi-asserted-by":"crossref","first-page":"199","DOI":"10.18388\/abp.2010_2395","article-title":"Interval hypoxic training in complex treatment of helicobacter pylori-associated peptic ulcer disease","volume":"57","author":"Semen","year":"2010","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.phrs.2026.108437_bib252","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"INPULSIS trial investigators, efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib253","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2026.108437_bib254","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"FIBRONEER-IPF Trial Investigators, Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib256","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121048","article-title":"Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2","volume":"309","author":"Antar","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib257","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"ASCEND Study Group, A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib258","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000001089","article-title":"Evidence from recent clinical trials in fibrotic interstitial lung diseases","volume":"30","author":"Cottin","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib259","unstructured":"Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEERTM-ON) - PubMed, (n.d.)."},{"key":"10.1016\/j.phrs.2026.108437_bib260","article-title":"Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib261","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0206-2022","article-title":"Phosphodiesterase 4B inhibition: A potential novel strategy for treating pulmonary fibrosis","volume":"32","author":"Kolb","year":"2023","journal-title":"Eur. Respir. Rev."},{"issue":"22","key":"10.1016\/j.phrs.2026.108437_bib262","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in Patients with Progressive Pulmonary Fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.phrs.2026.108437_bib263","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib264","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(16)30044-3","article-title":"Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"4","author":"Behr","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib265","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13287-025-04490-4","article-title":"Engineerable mesenchymal stem cell-derived extracellular vesicles as promising therapeutic strategies for pulmonary fibrosis","volume":"16","author":"Chen","year":"2025","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib266","article-title":"Idiopathic pulmonary fibrosis: cellular heterogeneity, mechanisms, and therapeutic implications","volume":"6","author":"Zuo","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.phrs.2026.108437_bib267","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/ijmm.2021.4849","article-title":"Astragaloside IV alleviates silica-induced pulmonary fibrosis via inactivation of the TGF-\u03b21\/Smad2\/3 signaling pathway","volume":"47","author":"Li","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113812","article-title":"Honokiol ameliorates silica-induced lung fibrosis by inhibiting macrophage pyroptosis via modulating cGAS\/STING signaling","volume":"146","author":"Zhou","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib269","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12890-024-03250-z","article-title":"Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization","volume":"24","author":"Bao","year":"2024","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib270","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11418-025-01896-5","article-title":"Mechanism study of the effects of astragaloside IV and quercetin on idiopathic pulmonary fibrosis","volume":"79","author":"Luo","year":"2025","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib271","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1002\/ptr.7062","article-title":"Evodiamine alleviates lipopolysaccharide-induced pulmonary inflammation and fibrosis by activating apelin pathway","volume":"35","author":"Ye","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157566","article-title":"Brusatol modulates autophagy to ameliorate pulmonary fibrosis by targeting Nrf2 in silicosis","volume":"149","author":"Kang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2026.108437_bib273","article-title":"The ameliorative effects of arctiin and arctigenin on the oxidative injury of lung induced by silica via TLR-4\/NLRP3\/TGF-\u03b2 signaling pathway","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2026.108437_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119940","article-title":"Licochalcone B attenuates pulmonary fibrosis via inhibiting ZBP1-dependent PANoptosis","volume":"349","author":"Ren","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173352","article-title":"Salvianolic acid B and sodium tanshinone II a sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process","volume":"883","author":"Jiang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib276","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102230","article-title":"Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-\u03b21\/Smad2\/3 pathway","volume":"81","author":"Jiao","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib277","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fphar.2015.00215","article-title":"Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats","volume":"6","author":"Gao","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib278","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-08-3393","article-title":"Naringenin: A potential immunomodulator for inhibiting lung fibrosis and metastasis","volume":"69","author":"Du","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.108437_bib279","first-page":"2321","article-title":"Baicalin alleviates bleomycin\u2011induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K\/AKT signaling pathway","volume":"21","author":"Zhao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2026.108437_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114375","article-title":"Puerarin alleviates silicon dioxide-induced pulmonary inflammation and fibrosis via improving autophagolysosomal dysfunction in alveolar macrophages of murine mice","volume":"152","author":"Su","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib281","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1002\/ptr.7210","article-title":"Silibinin alleviates silica-induced pulmonary fibrosis: Potential role in modulating inflammation and epithelial-mesenchymal transition","volume":"35","author":"Ali","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116483","article-title":"Nano-enabled delivery of diosgenin and emodin ameliorates respirable silica dust-induced pulmonary fibrosis silicosis in rats","volume":"279","author":"Sherekar","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.phrs.2026.108437_bib283","first-page":"322","article-title":"Matrine attenuates bleomycin-induced pulmonary injury partially via modulating mononuclear phagocyte phenotype switching in mice","volume":"33","author":"Li","year":"2017","journal-title":"Chin. J. Pathophysiol."},{"key":"10.1016\/j.phrs.2026.108437_bib284","first-page":"53","article-title":"Effects of Oxymatrine on Balance of Th1\/Th2 in Rats with Pulmonary Fibrosis","volume":"24","author":"Xu","year":"2010","journal-title":"Acad. J. Shanghai Univ. Tradit. Chin. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib285","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.toxlet.2013.03.009","article-title":"Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-\u03baB dependant TGF-\u03b2 activation: A biphasic experimental study","volume":"219","author":"Chitra","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2026.108437_bib286","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00109-015-1283-1","article-title":"Berberine inhibits smad and non-smad signaling cascades and enhances autophagy against pulmonary fibrosis","volume":"93","author":"Chitra","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib287","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/21691401.2020.1814315","article-title":"Protective effects of isorhynchophylline against silicon-dioxide-induced lung injury in mice","volume":"48","author":"Qiu","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108437_bib288","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbrc.2020.04.023","article-title":"Triptolide alleviates radiation-induced pulmonary fibrosis via inhibiting IKK\u03b2 stimulated LOX production","volume":"527","author":"Guo","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108437_bib289","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/cbin.11220","article-title":"Artesunate inhibits myofibroblast formation via induction of apoptosis and antagonism of pro-fibrotic gene expression in human dermal fibroblasts","volume":"43","author":"Larson","year":"2019","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.phrs.2026.108437_bib290","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/jcmm.13725","article-title":"Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"22","author":"Qian","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib291","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2147\/DDDT.S361748","article-title":"Ginsenoside Rb1 alleviates bleomycin-induced pulmonary inflammation and fibrosis by suppressing central nucleotide-binding oligomerization-, leucine-rich repeat-, and pyrin domains-containing protein three inflammasome activation and the NF-\u03baB pathway","volume":"16","author":"Liu","year":"2022","journal-title":"Drug. Des. Devel Ther."},{"key":"10.1016\/j.phrs.2026.108437_bib292","first-page":"29","article-title":"Asiaticoside attenuates bleomycin-induced interstitial pulmonary fibrosis","volume":"30","author":"Ye","year":"2016","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2026.108437_bib293","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.18632\/aging.202420","article-title":"Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1\u03b1 and NF-\u03baB expression","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.phrs.2026.108437_bib294","unstructured":"S. Ding, H. Wang, M. Wang, L. Bai, P. Yu, W. Wu, Resveratrol alleviates chronic \u201creal-world\u201d ambient particulate matter-induced lung inflammation and fibrosis by inhibiting NLRP3 inflammasome activation in mice."},{"key":"10.1016\/j.phrs.2026.108437_bib295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-020-03737-3","article-title":"Protective effects of curcumin on bleomycin-induced changes in lung glycoproteins","volume":"469","author":"Durairaj","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2026.108437_bib296","doi-asserted-by":"crossref","first-page":"L616","DOI":"10.1152\/ajplung.00002.2009","article-title":"Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury","volume":"298","author":"Smith","year":"2010","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phrs.2026.108437_bib297","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/ijms24031857","article-title":"Effects of green tea polyphenol epigallocatechin-3-gallate on markers of inflammation and fibrosis in a rat model of pulmonary silicosis","volume":"24","author":"Adamcakova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib298","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.12.009","article-title":"Emodin suppresses TGF-\u03b21-induced epithelial-mesenchymal transition in alveolar epithelial cells through notch signaling pathway","volume":"318","author":"Gao","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108437_bib299","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1089\/ars.2018.7569","article-title":"Tanshinone IIA activates nuclear factor-erythroid 2-related factor 2 to restrain pulmonary fibrosis via regulation of redox homeostasis and glutaminolysis","volume":"30","author":"An","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2026.108437_bib300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109024","article-title":"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-\u03b21\/smad signaling","volume":"319","author":"Feng","year":"2020","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.phrs.2026.108437_bib301","unstructured":"Y. Chen, Anti-pulmonary fibrosis effectand mechanism of acetylshikonin, Wenzhou University, n.d."},{"key":"10.1016\/j.phrs.2026.108437_bib302","first-page":"951","article-title":"Thymoquinone-PLGA-PVA nanoparticles ameliorate bleomycin-induced pulmonary fibrosis in rats via regulation of inflammatory cytokines and iNOS signaling","volume":"9","author":"Saghir","year":"2019","journal-title":"Anim. (Basel)"},{"key":"10.1016\/j.phrs.2026.108437_bib303","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12192-015-0654-4","article-title":"Salidroside protects against bleomycin-induced pulmonary fibrosis: Activation of Nrf2-antioxidant signaling, and inhibition of NF-\u03baB and TGF-\u03b21\/smad-2\/-3 pathways","volume":"21","author":"Tang","year":"2016","journal-title":"Cell. Stress. Chaperon-.-."},{"key":"10.1016\/j.phrs.2026.108437_bib304","first-page":"968","article-title":"Schisandrin B combined with platycodin D ameliorates pulmonary fibrosis by regulating macrophage M1\/M2 polarization via inhibition of JAK2\/STAT6 pathway","volume":"57","author":"Sun","year":"2026","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"10.1016\/j.phrs.2026.108437_bib305","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.fct.2017.06.016","article-title":"Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-\u03b21\/smad 2\/3 signaling","volume":"106","author":"Ko","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2026.108437_bib306","doi-asserted-by":"crossref","first-page":"18252","DOI":"10.1021\/acs.jafc.5c01904","article-title":"Targeted inhibition of aldose reductase by isoliquiritigenin suppresses fatty acid synthesis to inhibit macrophage M2 polarization and alleviate pulmonary fibrosis","volume":"73","author":"Mei","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2026.108437_bib307","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ptr.8070","article-title":"Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1-mediated macrophage and alveolar type 2 cell senescence","volume":"38","author":"Li","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2026.108437_bib308","doi-asserted-by":"crossref","first-page":"45133","DOI":"10.18632\/oncotarget.16456","article-title":"Triptolide mitigates radiation-induced pneumonitis via inhibition of alveolar macrophages and related inflammatory molecules","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2026.108437_bib309","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.biopha.2017.09.037","article-title":"Baicalin alleviates radiation-induced epithelial-mesenchymal transition of primary type II alveolar epithelial cells via TGF-\u03b2 and ERK\/GSK3\u03b2 signaling pathways","volume":"95","author":"Lu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2026.108437_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123925","article-title":"Crosstalk between macrophages and diverse immune cells accelerates the development of acute lung injury","volume":"380","author":"Huang","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2026.108437_bib311","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12967-025-06447-w","article-title":"Matrix metalloproteinase-driven epithelial-mesenchymal transition: Implications in health and disease","volume":"23","author":"Khalili-Tanha","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108437_bib312","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-020-03737-3","article-title":"Protective effects of curcumin on bleomycin-induced changes in lung glycoproteins","volume":"469","author":"Durairaj","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2026.108437_bib313","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41401-024-01376-8","article-title":"Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages","volume":"46","author":"You","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2026.108437_bib314","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2147\/DDDT.S361748","article-title":"Ginsenoside Rb1 alleviates bleomycin-induced pulmonary inflammation and fibrosis by suppressing central nucleotide-binding oligomerization-, leucine-rich repeat-, and pyrin domains-containing protein three inflammasome activation and the NF-\u03baB pathway","volume":"16","author":"Liu","year":"2022","journal-title":"Drug. Des. Devel Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182600352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:14:19Z","timestamp":1793693659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182600352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":314,"alternative-id":["S104366182600352X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108437","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconfiguring the macrophage-centric intercellular network in pulmonary fibrosis: Emerging perspectives and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108437"}}